MJardin Group Granted Cannabis Cultivation License by Health Canada for Nova Scotia Facility

DENVER–(BUSINESS WIRE)–MJardin Group, Inc. (“MJardin” or the “Company”) (CSE:MJAR), a leader in cannabis management, is pleased to announce that the recently opened cultivation and extraction facility in Lower Sackville, Nova Scotia owned by AtlantiCann Medical Inc. (“AMI”), in which MJardin has a 50% equity interest, has been granted a license by Health Canada for cannabis cultivation.

The new state-of-the-art, 48,000 square foot cultivation and extraction facility has a production capacity of 6,000 kg per year, with expansion planned for an additional 20,000 square feet by the end of 2019. AMI intends to seek GMP certification for the facility in 2019.

Since federal legalization in October, the Canadian cannabis market has struggled to meet strong consumer demand due to supply shortages.


Rishi Gautam, Chairman and Chief Executive Officer of MJardin Group.

We are very pleased to receive our cultivation license from Health Canada and will leverage our decade-long experience in cannabis cultivation to assist in bringing significant supply online to meet growing consumer demand for high quality medicinal and adult-use cannabis products.

“Our newly granted cultivation license is an important milestone and a key operational development for AMI. We are proud of our growing footprint in Atlantic Canada with the support of MJardin. With the first harvest at our state-of-the-art facility expected to be complete in the spring of 2019, we are well positioned to provide innovative, premium cannabis products to help patients cope with their ailments,” said Christine Halef, President of AtlantiCann Medical Inc.

About MJardin Group

MJardin is a global cannabis management platform with extensive experience in cultivation, processing, distribution and retail. For over 10 years, MJardin has refined cultivation methodologies, developed state of the art facilities and implemented vertical integration for and on behalf of license owners. As a well-capitalized organization, MJardin continues to pursue strategic expansion and M&A opportunities across global legal cannabis markets. MJardin is based in Denver Colorado, with offices in Toronto, Canada and Barcelona, Spain. For more information, please visit www.mjardin.com.

About AtlantiCann Medical Inc.

AtlantiCann Medical Inc. (AMI) was founded in 2013 with an application submitted under the MMPR program with the primary objective of advancing the uses of medicinal cannabis. Since then the 48,000 square foot facility, located in Lower Sackville, NS has completed construction and received a cultivation license from Health Canada. MJardin, a company with extensive experience in producing cannabis, is a 50% equity owner in AMI. With their combined knowledge and experience in cultivation and pharmaceuticals, they will strive to provide excellence, reliability and innovation in this burgeoning sector.

Original Press Release

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter